| Type | Active Pharmaceutical ingredient |
| CAS No. | 357336-20-0 |
| Chemical Formula | C11H20N2O2 |
| Appearance | white powder |
| Packaging | customized |
| Assay | ≥99% |
| Related Products | Iopamidol, Iohexol, 2,6-Dichloropurine |
| CAS No. | 357336-20-0 |
| Chemical Formula | C11H20N2O2 |
| Appearance | white powder |
| Packaging | customized |
| Assay | ≥99% |
| Boiling Point | 409.3±28.0℃ |
| Density | 1.062 |
Brivaracetam reduces excessive neuronal excitation and prevents epileptic seizures by binding reversibly to LTG receptors on neurons, thereby regulating the release of neurotransmitters at the presynaptic level.
Common side effects include dizziness, fatigue, drowsiness, headache, nausea, and irritability. Some patients may experience mood swings or behavioral changes, such as anxiety and irritability.
The initial dosage is typically 50 milligrams per day. Depending on the patient's response and tolerance, the dose can be gradually increased to up to 200 milligrams per day. The specific dosage should follow the guidance of a healthcare professional.
Brivaracetam should be stored in a dry, cool place, away from direct sunlight and high temperatures. Keep the medication out of reach of children and store it according to the instructions on the medication packaging.